QuickStats: Percentage of Adults Aged 50–75 Years Who Met Colorectal Cancer (CRC) Screening Recommendations — National Health Interview Survey, United States, 2018

March 20, 2020

March is Colorectal Awareness Month. 67% of U.S. adults aged 50–75 years met the U.S. Preventive Services Task Force recommendations for colorectal cancer screening. Most persons (60.6%) had a colonoscopy in the past 10 years. Cancer screening leads to early detection, and early detection saves lives.

Source: National Health Interview Survey, 2018. https://www.cdc.gov/nchs/nhis.htm.


Breast Cancer Screening Among Women by Nativity, Birthplace, and Length of Time in the United States

October 9, 2019

Questions for Lead Author Tainya Clarke, Health Statistician, of “Breast Cancer Screening Among Women by Nativity, Birthplace, and Length of Time in the United States.”

Q: Why did you decide to do a report on mammography screening among women by nativity?

TC: There is currently limited published research on how nativity, birthplace and/or lifetime in the US of ethnically diverse foreign-born women affect the likelihood of having a mammogram.

Q: How did the data vary by nativity, birthplace and lifetimes in the United States?

TC: Foreign-born women were less likely than US-born women to have ever had a mammogram. If evaluated on equal standing for selected sociodemographic factors e.g. income, education, marital status; foreign-born women residing in the United States for less than 25% of their lifetime were as likely as US-born women to have met the U.S. Preventive Services Task Force (USPSTF) recommendations, while those residing in the United States for 25% or more of their lifetime were more likely to do so than US-born women.

Q: Was there a specific finding in your report that surprised you?

TC: Yes, we found that after controlling for the sociodemographic factors examined in this research, foreign-born women from some countries such as Mexico, and Central America were more likely to have received mammogram compared with US-born women.

Q: How did you obtain this data for this report?

TC: The data was obtained from the National Center for Health Statistics NCHS and most of the information used are publicly available. Information such as country of birth and year of immigration may be obtained through the CDC’s Research Data Center (RDC) by submitting a proposal stating the reason for use.

Q: What is the take home message for this report?

TC: Length of lifetime in the US among foreign-born women have some positive affect on the likelihood of having a mammogram among foreign-born women. However, analyses indicate that the absence of some sociodemographic factors such as health insurance coverage, usual place for medical care, and poor standing in some factors such as educational attainment, seeing a doctor in the past year and income, also play a role in the likelihood of getting a mammogram among foreign-born women.

QuickStats: Age-Adjusted Death Rates from Female Breast Cancer by State — National Vital Statistics System, United States, 2017

July 12, 2019

In 2017, the overall age-adjusted death rate for female breast cancer was 19.9 per 100,000 population.

The highest death rates were in Mississippi (25.5), DC (24.3), and Louisiana (23.6).

The lowest death rates were in Hawaii (15.6), Alaska (16.3), New Hampshire (16.3), Wyoming (16.5), Rhode Island (16.6), Minnesota (16.7), South Dakota (17.3), Wisconsin (17.4), and Vermont (17.4).

Source: National Center for Health Statistics, National Vital Statistics System, mortality file. https://www.cdc.gov/nchs/nvss/deaths.htm.


2017 Final Deaths, Leading Causes of Death and Life Tables Reports Released

June 24, 2019

NCHS released a report that presents the final 2017 data on U.S. deaths, death rates, life expectancy, infant mortality, and trends, by selected characteristics such as age, sex, Hispanic origin and race, state of residence, and cause of death.

Key Findings:

  • In 2017, a total of 2,813,503 deaths were reported in the United States.
  • The age-adjusted death rate was 731.9 deaths per 100,000 U.S. standard population, an increase of 0.4% from the 2016 rate.
  • Life expectancy at birth was 78.6 years, a decrease of 0.1 year from the 2016 rate.
  • Life expectancy decreased from 2016 to 2017 for non-Hispanic white males (0.1 year) and non-Hispanic black males (0.1), and increased for non-Hispanic black females (0.1).
  • Age-specific death rates increased in 2017 from 2016 for age groups 25–34, 35–44, and 85 and over, and decreased for age groups under 1 and 45–54.
  • The 15 leading causes of death in 2017 remained the same as in 2016 although, two causes exchanged ranks.
  • Chronic liver disease and cirrhosis, the 12th leading cause of death in 2016, became the 11th leading cause of death in 2017, while Septicemia, the 11th leading cause of death in 2016, became the 12th leading cause of death in 2017.
  • The infant mortality rate, 5.79 infant deaths per 1,000 live births in 2017, did not change significantly from the rate of 5.87 in 2016.

NCHS also released the 2017 U.S. Life Tables and Leading Causes of Death Reports.

QuickStats: Age-Adjusted Death Rates from Prostate Cancer, by Race/ Ethnicity — National Vital Statistics System, United States, 1999–2017

June 14, 2019

In 2017, the age-adjusted prostate cancer death rate among all males was 18.7 per 100,000, down from 31.3 in 1999.

During 1999–2017, non-Hispanic black males had the highest prostate cancer death rate. In 2017, the rate for non-Hispanic black males was 36.8, compared with 17.8 for non-Hispanic white males and 15.4 for Hispanic males.

Source: National Vital Statistics System, Mortality, 1999–2017. https://wonder.cdc.gov/ucd-icd10.html.



Trends in Cancer and Heart Disease Death Rates Among Adults Aged 45–64: United States, 1999–2017

May 22, 2019

Questions for Sally Curtin, M.A., Statistician, and Lead Author of “Trends in Cancer and Heart Disease Death Rates Among Adults Aged 45–64: United States, 1999–2017.”

Q:  Why are death rates from cancer dropping steadily over time and why are death rates from heart disease starting to rise?

SC: The death rates are a reflection of a few things—the prevalence of a disease, how often is occurs in the population, as well as its treatment and survival.  As this is purely a statistical analysis, others can speak to the trends in these factors.

Q:  You write that cancer treatments might contribute to subsequent heart disease for patients and might help explain the increase in heart disease mortality.  Which cancer treatments are contributing to this subsequent heart disease among cancer patients?

SC: The cardiotoxicity of cancer treatments is just one way that these two seemingly disparate diseases are related.  It is well known in the medical community that radiation and many chemotherapies can increase the risk of subsequent heart disease. In our analysis, we didn’t examine which treatments might be contributing to heart disease risk.

Q:  Which groups are seeing the biggest decline in cancer death rates?

SC: Non-hispanic black men, who have the highest cancer death rates, also had the largest percentage decline over the period at 34%.  In general, the percentage declines were greater for men than for women.

Q:  Which groups are seeing the biggest increase in heart disease death rates?

SC: Non-hispanic white women had a 12% increase since 2009 in heart disease death rates, the greatest of all groups.  In total, middle-aged women had a 7% recent increase compared with 3% for middle-aged men.  Another interesting finding is that Hispanic women, who had the lowest heart disease death rates of all groups, had a 37% decline over the period, the only group to experience a decline over the entire period.

Q:  Does this analysis suggest that cancer will not overtake heart disease as the leading cause of death in the U.S., which many have been predicting?

SC:  The focus of this report was on the middle-age population, and Cancer is the leading cause of death in the 45-64 year old population as shown in this report, whereas heart disease remains the leading cause in the total population.  While we do not make predictions about what data trends will look like in the future, it is safe to say that if the recent upturn in heart disease continues, it is unlikely that this switch will occur anytime soon.


QuickStats: Percentage of U.S. Women Aged 50–74 Years Who Have Ever Had Breast Cancer by Race and Hispanic Origin

January 25, 2019

During 2015–2017, 5.3% of U.S. women aged 50–74 years had ever been told they had breast cancer.

Non-Hispanic white women were more likely to have ever been told they had breast cancer (6.1%) compared with Hispanic women (3.2%) and non-Hispanic black women (3.6%).

There was no significant difference in the prevalence of breast cancer between Hispanic and non-Hispanic black women.

Source: National Health Interview Survey, 2015–2017